MPC

News, insights, analysis and data

MPC overview

Stories about MPC

Picture of the Company

Matrix Partners raises $750m

The China-focused arm of the US venture capital firm will continue to target technology and healthcare for its new fund.

Picture of the Company

Fifth fund of funds for MPC

German fund of funds investor MPC Capital is looking to raise E50m from private investors for a fund managed by Global Vision.

MPC contact information

Offices

marker iconRoom 2601, Taikang Financial Building, Building 1, No. 38, East Third Ring Road North, Chaoyang District, Beijing, 100026, China
Showing 1 of 2 MPC offices

Contacts

NameJob titleLocationEmail
Key Contact
user imageMr. Tong Ti
Job titleInvestment Director
LocationBeijing, China
Emaillock image----------
Key Contact
user imageMs. Hu Yunqiu
Job titleVice President, Investments
LocationBeijing, China
Emaillock image-----
user imageMr. Zhang Chao
Job titleManaging Director
LocationBeijing, China
Emaillock image------
user imageMr. Xu Chuansheng
Job titleFounding Managing Partner
LocationBeijing, China
Emaillock image--------

MPC funds managed

Closed funds: 8

FundFund sizeClose dateStrategy
Fund sizelock image---------
Close dateJul 2023
Strategylock image-------
Fund sizelock image--------
Close dateApr 2021
Strategylock image----------
Fund sizelock image-------
Close dateDec 2018
Strategylock image----------

Stories that mention MPC

China’s ‘herd mentality’ could threaten VC returns

Greater competition for a limited number of assets has diluted equity ownership, delegates told an industry conference on Tuesday.

PEI 300 2019: Tech strategy helps three firms into top 20

The good times are rolling for technology and innovation-focused managers.

Startup valuation drop is a welcomed change

Venture capital experts believe the recent wave of lower valuations for certain unicorn startups is nothing to worry about; rather, they think it will push investors to be more selective and realistic.

In memoriam: Warren Hellman

Warren Hellman, the co-founder of US buyout firm Hellman & Friedman, has died at the age of 77 after a battle with leukemia.